UCPVax 1mg/2ml clinical trials

MATVAC-1 : EVALUATION OF UCPVAX VACCINE +/- PEMBROLIZUMAB COMBINED WITH STANDARD TREATMENT AS ADJUVANT THERAPY IN PATIENTS WITH UNMETHYLATED MGMT GLIOBLASTOMA

This study is looking at new treatments for a type of brain cancer called glioblastoma. It's testing a vaccine called UCPVAX, sometimes with another drug called pembrolizumab, alongside standard care, to see if it helps people live longer after treatment.